MedPath

Breads Made With Triticum Heritage Varieties: Effect on Post-prandial Glycemia and Insulinemia

Not Applicable
Completed
Conditions
Dietary Modification
Interventions
Other: Bio2+S. cerevisiae yeast
Other: Bologna 00+S. cerevisiae yeast
Other: ICARDA+S. cerevisiae yeast
Other: ICARDA+sourdough
Other: Grossi+sourdough
Other: Bologna 1+S. cerevisiae yeast
Other: Bologna 1+sourdough
Other: Bio 2+sourdough
Registration Number
NCT03710200
Lead Sponsor
University of Parma
Brief Summary

Wheat is one of the most important crop for humans and it represents a source of multiple nutrients, dietary fiber and bioactive compounds, especially if consumed as wholegrain. Several studies have suggested that Triticum heritage varieties could present a healthier and better nutritional profile than modern wheats, by providing more vitamins, minerals and nutraceutical compounds. Although the effect of ancient grain consumption have been partially investigated in both animal and human studies, the potential impact of Triticum heritage varieties compared to modern ones on post-prandial glucose metabolism is still unclear. Thus, the aim of the study was to evaluate the impact on post-prandial glycaemia and insulinemia of different types of breads formulated with flours derived from mix of heritage varieties belonging to the Triticum genus selected and cultivated in specific areas of Emilia Romagna region, compared to breads made with conventional/modern wheat flours.

Detailed Description

Cereal grain based products constitute a major part of the daily diet, and wheat is the most important crop for humans representing a source of multiple nutrients, dietary fiber and bioactive compounds, especially if consumed as wholegrain. Depending on its physical and chemicals properties, such as structure of grains, granular size of semolina, quantity and quality of fiber and phytochemicals, amylose/amylopectin ratio, wheat may vehicle protective effects on human health. After the Green Revolution, most of wheat species grown are hybrids, which derive from ancient wheat over the last 100 to 150 years. The main results of this revolution were the development of modern varieties characterized by higher yield, a reduced susceptibility to disease and insects, an increase tolerance to environmental stresses, a homogeneous maturation and a better gluten quality, compared to ancient wheat. At the same time, a decrease in genetic variability as well as a gradual depletion of the nutritional and nutraceutical properties of the wheat occurred. However, over the last years, the increase of diet-related chronic disease led to the nutritional improvement of wheat for ameliorating its health potential. Nowadays, the higher value of whole grains than refined grains is recognized, while the nutritional effects of ancient versus modern grains is still controversial. Generally, ancient species are higher in vitamins, such as folate, niacin and vitamin B6, as well as in minerals such as calcium, iron, magnesium and phosphor compared to modern species, however evidence linked to their real health in vivo effects is still lacking. Therefore, the aim of the present study is to evaluate the nutritional profile of eight breads made with ancient (Triticum heritage varieties) or modern grains on the plasma response of glucose and insulin.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria

-generally healthy

Exclusion Criteria
  • BMI≥30kg/m2
  • have any health conditions (including anemia and metabolic conditions such as hypertension, dyslipidemia, impaired glucose intolerance or diabetes)
  • have celiac disease
  • currently taking any prescription medication for chronic diseases (including psychiatric) dietary supplements affecting the metabolism
  • Women who are pregnant or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Bio2+S. cerevisiae yeastBio2+S. cerevisiae yeastBread made with mix Bio2 flour (type 1) (heritage mix varieties)+S. cerevisiae yeast
Bologna 00+S. cerevisiae yeastBologna 00+S. cerevisiae yeastBread made with Bologna flour (type 00) (modern variety)+S. cerevisiae yeast
ICARDA+S. cerevisiae yeastICARDA+S. cerevisiae yeastBread made with Icarda mix (type 1) (heritage mix varieties)+S. cerevisiae yeast
ICARDA+sourdoughICARDA+sourdoughBread made with mix Icarda flour (type 1) (heritage mix varieties)+sourdough
Grossi+sourdoughGrossi+sourdoughBread made with mix Grossi flour (type 1) (heritage mix varieties)+sourdough
Bologna 1+S. cerevisiae yeastBologna 1+S. cerevisiae yeastBread made with Bologna flour (type 1) (modern variety)+S. cerevisiae yeast
Bologna 1+sourdoughBologna 1+sourdoughBread made with Bologna flour (type 1) (modern variety)+sourdough
Bio2+sourdoughBio 2+sourdoughBread made with mix Bio2 flour (type 1) (heritage mix varieties)+sourdough
Primary Outcome Measures
NameTimeMethod
Post-prandial glycemic response2 hours (-10 and 0 -fasting-, 15, 30, 45, 60, 90, 120 minutes)

Post-prandial glycemic response (iAUC)

Secondary Outcome Measures
NameTimeMethod
Post-prandial response for insulin2 hours (-10 and 0 -fasting-, 15, 30, 45, 60, 90, 120 minutes)

Post-prandial response for insulin (iAUC)

Maximum peak for glucose and insulin2 hours (-10 and 0 -fasting-, 15, 30, 45, 60, 90, 120 minutes)

maximum value of postprandial glucose and insulin response

Trial Locations

Locations (1)

Department of Food and Drugs, University of Parma

🇮🇹

Parma, Italy

© Copyright 2025. All Rights Reserved by MedPath